Brief introduction of Tenofovir

Tenofovir is a nucleotide reverse transcriptase inhibitor used to treat HIV and chronic hepatitis B.

Physical and chemical properties of Tenofovir:

Product name: Tenofovir

Alias: PMPA; 1-(6-aminopurin-9-yl)propan-2-yloxymethylphosphonic acid; (R)-9-[2-(phosphonomethoxy)propyl]adenine; (R)-(1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid; (R)-9-[(2-Phosphonomethoxyl)propyl]Adenine; (R)-9-(2-phosphonomethoxypropyl)adenine

Molecular formula: 147127-20-6

Molecular weight:287.22

Molecular structure: 

Tenofovir references:

[1]. Murphy RA, et al. Establishment of HK-2 Cells as a Relevant Model to Study Tenofovir-Induced Cytotoxicity. Int J Mol Sci. 2017 Mar 1;18(3).

[2]. Musumeci G, et al. M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures. Sci Rep. 2017 Feb 1;7:41018.

[3]. Wahl A, et al. Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model. Sci Rep. 2017 Feb 1;7:41098.

[4]. Menne S, Cote PJ, Korba BE, Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother. 2005 Jul;49(7):2720-8.

Other information:

Diethyl p-toluene sulfonyloxy methyl phosphonate(DESMP) is an important intermediate of Tenofovir, which plays an important role in the treatment of AIDS.